Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaydale Plc Regulatory News (HAYD)

Share Price Information for Haydale Plc (HAYD)

Share Price is delayed by 15 minutes
Get Live Data
0.325    -0.0025 (-0.76%)
Bid:
0.32
Ask:
0.33
Spread: 0.01 (3.125%)
Market Cap: £25.27m
HAYD Live PriceLast checked at - London Stock Exchange

Intraday Haydale Plc Share Chart

PDMR Dealing

25 Apr 2017 07:00

RNS Number : 1878D
Haydale Graphene Industries PLC
25 April 2017
 

The information contained within this announcement is deemed by the Group to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR"). Upon the publication of this announcement via a Regulatory Information Service ("RIS"), this inside information is now considered to be in the public domain.

 

 

For immediate release

25 April 2017

Haydale Graphene Industries plc

("Haydale" or the "Company")

PDMR Dealing

The Company announces that it has received a notification of dealings in restricted securities from Gerry Boyce, Managing Director of Haydale Composite Solutions Limited, a subsidiary of the Company. Mr Boyce has sold 108,000 ordinary shares in the Company at a price of £1.70 per share.

The notification set out below is provided in accordance with the requirements of the EU Market Abuse Regulation.

 

Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014

1

Details of the person discharging managerial responsibilities/person closely associated

a.

Name

Gerard Stephen Boyce

 

2

Reason for notification

 

 

 

a.

Position/Status

Managing Director of Haydale Composite Solutions Ltd

b.

Initial notification/

Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Haydale Graphene Industries Plc

b.

LEI

213800KNULBQFF25IE72

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the financial instrument, type of instrumentIdentification Code

Ordinary Shares of 2p each

GB00BKWQ1135

b.

Nature of the transaction

Sale of shares

 

c.

Price(s) and volume(s)

Price(s)

Volume(s)

 £1.70

108,000

 

 

d.

Aggregated information

 

- Aggregated Volume

 

- Price

108,000 shares at £1.70

 

e.

Date of the transaction

2017-04-21

f.

Place of the transaction

XLON (AIM Market)

 

For further information:

Haydale Graphene Industries plc

Ray Gibbs, Chief Executive Officer

Tel: +44 (0) 1269 842 946

Matt Wood, Finance Director

www.haydale.com

Trevor Phillips, Head of Communications

Cairn Financial Advisers LLP (Nominated Adviser)

Tony Rawlinson / Emma Earl

Tel: +44 (0) 20 7213 0880

Cantor Fitzgerald Europe (Broker)

David Foreman / Will Goode (Corporate Finance)

Tel: +44 (0) 20 7894 7000

David Banks / Mark Westcott (Sales)

 

Media enquiries:

Buchanan

Henry Harrison-Topham / Jamie Hooper

Tel: +44 (0) 20 7466 5000

haydale@buchanan.uk.com

www.buchanan.uk.com

 

Notes to Editors

Haydale is a global technologies and materials group that facilitates the integration of nanomaterials into the next generation of commercial technologies and industrial materials. With expertise in graphene, silicon carbide and other nanomaterials, Haydale is able to deliver improvements in electrical, thermal and mechanical properties, as well as toughness. Haydale has granted patents for its technologies in Europe, USA and China and operates from four facilities in the UK, USA and the Far East.

 

For more information please visit:www.haydale.comTwitter: @haydalegraphene

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHOKQDBKBKBPQB
Date   Source Headline
22nd Nov 20245:27 pmRNSHolding(s) in Company
21st Nov 202411:48 amRNSDirectorate Change
15th Nov 20242:06 pmRNSHolding(s) in Company
14th Nov 20242:45 pmRNSHolding(s) in Company
13th Nov 20242:10 pmRNSResult of General Meeting and TVR
28th Oct 20245:12 pmRNSResult of Retail Offer
28th Oct 20247:00 amRNSResult of Fundraising
25th Oct 20242:20 pmRNSRetail Offer
25th Oct 20242:15 pmRNSProposed Fundraise to raise up to £3.5 million
9th Jul 20247:00 amRNSNew Agreement Worth US$4.0 million
20th May 20247:00 amRNSTrading Update
2nd May 20247:00 amRNSGrant of Share Options and PDMR Dealing
12th Mar 20247:00 amRNSInterim Results
26th Jan 20247:00 amRNSGrant of Options & Surrender of Existing Options
22nd Jan 20247:00 amRNSHaydale selected for Innovate UK Scaleup Programme
7th Dec 202311:36 amRNSResult of AGM
7th Dec 202311:34 amRNSDirectorate Change
6th Dec 20237:00 amRNSHaydale awarded SMART funding
16th Nov 20232:31 pmRNSHolding(s) in Company
13th Nov 20237:00 amRNSPosting of Annual Report & Notice of AGM
1st Nov 20237:00 amRNSTotal Voting Rights
26th Oct 20237:00 amRNSFinal Results
9th Oct 20238:23 amRNSHolding(s) in Company
5th Oct 20231:43 pmRNSDirector/PDMR Shareholding & Total Voting Rights
4th Oct 20234:46 pmRNSHolding(s) in Company
3rd Oct 20233:48 pmRNSResult of General Meeting
2nd Oct 20237:00 amRNSTotal Voting Rights
22nd Sep 20234:30 pmRNSResult of Retail Offer and Total Voting Rights
15th Sep 20236:12 pmRNSResult of Fundraising
15th Sep 20234:00 pmRNSLaunch of Retail Offer
15th Sep 20233:00 pmRNSProposed Placing, Subscription & Retail Offer
15th Sep 20237:00 amRNSWarrant Expiry, Block Admission Cancellation & TVR
22nd Aug 20237:00 amRNSCollaboration with PETRONAS
4th Aug 20231:02 pmRNSHolding(s) in Company
2nd Aug 20237:00 amRNSDirectorate Change
24th Jul 20237:00 amRNSContract Award
13th Jul 20237:00 amRNSHaydale Delivers LPHW Prototype for Cadent
21st Jun 20237:00 amRNSTrading Update
5th Jun 20237:00 amRNSDirectorate Change
24th May 20237:00 amRNSHaydale to Contribute to the Development of FCHEVs
3rd May 20237:00 amRNSSMART Innovation to Accelerate Graphene Products
26th Apr 20233:06 pmRNSGrant of Share Options
12th Apr 20237:00 amRNSHaydale and Saint-Gobain Collaborate on hBN
16th Mar 20237:00 amRNSHaydale and City Energy Develop UFH with Plumbase
14th Mar 20238:15 amRNSBlock listing Interim Review
10th Mar 202311:05 amRNSSecond Price Monitoring Extn
10th Mar 202311:00 amRNSPrice Monitoring Extension
10th Mar 20237:00 amRNSDirectorate Change
1st Mar 20237:00 amRNSInterim Results
28th Feb 202311:38 amRNSHaydale and GEIC Proud to Partner for a Sixth Year

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.